Stock Scorecard
Stock Summary for Ionis Pharmaceuticals Inc (IONS) - $53.35 as of 7/23/2026 8:25:01 AM EST
Total Score
5 out of 30
Safety Score
49 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for IONS
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for IONS
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for IONS
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for IONS
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for IONS (49 out of 100)
| Stock Price Rating (Max of 10) | 9 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 5 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 10 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for IONS
Financial Details for IONS
Company Overview |
|
|---|---|
| Ticker | IONS |
| Company Name | Ionis Pharmaceuticals Inc |
| Country | USA |
| Description | Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California. |
| Sector Name | HEALTHCARE |
| Industry Name | BIOTECHNOLOGY |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 7/29/2026 |
Stock Price History |
|
| Last Day Price | 53.35 |
| Price 4 Years Ago | 37.77 |
| Last Day Price Updated | 7/23/2026 8:25:01 AM EST |
| Last Day Volume | 8,714,043 |
| Average Daily Volume | 3,634,305 |
| 52-Week High | 86.74 |
| 52-Week Low | 40.03 |
| Last Price to 52 Week Low | 33.28% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 36.53 |
| Sector PE | 103.31 |
| 5-Year Average PE | -72.67 |
| Free Cash Flow Ratio | 50.81 |
| Industry Free Cash Flow Ratio | 26.98 |
| Sector Free Cash Flow Ratio | 34.79 |
| Current Ratio Most Recent Quarter | 4.10 |
| Total Cash Per Share | 1.05 |
| Book Value Per Share Most Recent Quarter | 2.96 |
| Price to Book Ratio | 17.81 |
| Industry Price to Book Ratio | 5.08 |
| Sector Price to Book Ratio | 19.24 |
| Price to Sales Ratio Twelve Trailing Months | 8.34 |
| Industry Price to Sales Ratio Twelve Trailing Months | 11.87 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.99 |
| Analyst Buy Ratings | 12 |
| Analyst Strong Buy Ratings | 8 |
Share Statistics |
|
| Total Shares Outstanding | 165,263,000 |
| Market Capitalization | 8,816,781,050 |
| Institutional Ownership | 107.16% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 3.07% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -43.70% |
| Annual Earnings Growth | 16.06% |
| Reported EPS 12 Trailing Months | -2.03 |
| Reported EPS Past Year | -0.30 |
| Reported EPS Prior Year | -1.84 |
| Net Income Twelve Trailing Months | -326,583,000 |
| Net Income Past Year | -381,000,000 |
| Net Income Prior Year | -453,897,000 |
| Quarterly Revenue Growth YOY | 87.00% |
| 5-Year Revenue Growth | 5.30% |
| Operating Margin Twelve Trailing Months | -47.70% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 173,381,000 |
| Total Cash Past Year | 372,260,000 |
| Total Cash Prior Year | 242,077,000 |
| Net Cash Position Most Recent Quarter | -1,175,858,000 |
| Net Cash Position Past Year | -975,183,000 |
| Long Term Debt Past Year | 1,347,443,000 |
| Long Term Debt Prior Year | 1,245,485,000 |
| Total Debt Most Recent Quarter | 1,349,239,000 |
| Equity to Debt Ratio Past Year | 0.27 |
| Equity to Debt Ratio Most Recent Quarter | 0.27 |
| Total Stockholder Equity Past Year | 489,089,000 |
| Total Stockholder Equity Prior Year | 588,351,000 |
| Total Stockholder Equity Most Recent Quarter | 491,414,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -971,257,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -5.88 |
| Free Cash Flow Past Year | -320,027,000 |
| Free Cash Flow Prior Year | -546,227,000 |
Options |
|
| Put/Call Ratio | 2.36 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.36 |
| RSI | 0.00 |
| 50-Day SMA | 71.76 |
| 150-Day SMA | 51.23 |
| 200-Day SMA | 48.41 |
System |
|
| Modified | 7/23/2026 1:42:07 AM EST |